Accession Number: | 0001385508-19-000077 |
Date: | 2019-08-01 |
Issuer: | OPIANT PHARMACEUTICALS, INC. (OPNT) |
Original Submission Date: |
SKOLNICK PHIL
C/O OPIANT PHARMACEUTICALS, INC.
201 SANTA MONICA BLVD., SUITE 500
SANTA MONICA, CA 90401
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2019-08-01 | M | 10,000 | a | $9.00 | 10,000 | direct | ||
COMMON STOCK | 2019-08-01 | S | 8,442 | d | $11.66 | 1,558 | direct | ||
COMMON STOCK | 2019-08-02 | S | 1,558 | d | $11.30 | 0 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 9.0 | 2019-08-01 | deemed execution date | M | 10,000 (d) | 2018-08-06 | 2027-02-06 | common stock 10,000 | $9.00 | 90,000 | direct |
ID | footnote |
---|---|
f1 | the option was exercised pursuant to a rule 10b5-1 trading plan entered into by the reporting person. |
f2 | the shares were sold pursuant to a rule 10b5-1 trading plan entered into by the reporting person. |
f3 | this transaction was executed in multiple trades at prices ranging from $11.00 to $12.30. the price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
f4 | this transaction was executed in multiple trades at prices ranging from $11.15 to $11.51. the price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |